Caffeinated coffee enhances co-operative behavior in the mixed motive game in healthy volunteers

Nutritional Neuroscience

Volumn 12, Issue 1, 2009, Pages 21-27

  Tse, Wai S ^a   Chan, Chi Choi S ^a   Shiu, Shun Yan K ^a   Chung, Pik Yee A ^a   Cheng, Shuk Han ^a  

^a CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antidepressant; Caffeine; Co operation; Noradrenaline

Indexed keywords

CAFFEINE;

ADULT; ARTICLE; BEHAVIOR CHANGE; BLOOD PRESSURE MEASUREMENT; COFFEE; CONTROLLED STUDY; COOPERATION; DEPRESSION; DIETARY INTAKE; FEMALE; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; MALE; MOOD CHANGE; NORMAL HUMAN; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; SOCIAL BEHAVIOR; SOCIAL SUPPORT;

ADOLESCENT; ADULT; AFFECT; BLOOD PRESSURE; CAFFEINE; COFFEE; COOPERATIVE BEHAVIOR; CROSS-OVER STUDIES; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; GAME THEORY; HEART RATE; HUMANS; MALE; PLACEBOS; QUESTIONNAIRES; SOCIAL SUPPORT;

EID: 65349127168     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/147683009X388896     Document Type: Article

References (34)

1. Graham DM. Caffeine - its identity, dietary sources, intake and biological effects. Nutr Rev 1978; 36: 97-102.
2. Winston AP, Hardwick E, Jaberi N. Neuropsychiatric effects of caffeine. Adv Psychiatr Treat 2005; 11: 432-439.
3. Fredholm BB, Battig K, Holmen J et al. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev 1999; 51: 83-133.
4. Traversa U, de Angelis L, Della Loggia R et al. Effects of caffeine and chlor-desmethyldiazepam on fighting behavior of mice with different reactivity baselines. Pharmacol Biochem Behav 1985; 23: 237-241.
5. Wilson JF, Nugent NR, Baltes JE et al. Effects of low doses of caffeine on aggressive behavior of male rats. Psychol Rep 2000; 86: 941-946.
6. Cherek DR, Steinberg JL, Brauchi JT. Regular or decaffeinated coffee and subsequent human aggressive behavior. Psychiatry Res 1984; 11: 251-258.
7. El Yacoubi M, Costeintin J, Vaugeois JM. Adenosine A2A receptors and depression. Neurology 2003; 61 (Suppl 6): S82-S87.
8. Sezer G, Sezer Z, Tekol Y. Role of adenosine and adenosine A2A receptors in the antidepressant effect of amitriptyline. Eur Neuropsychopharmacol 2007; 17: S364.
9. Minor TR, Huang Q, Foley EA. Cytokine-purine interactions in behavioral depression in rats. Integr Physiol Behav Sci 2003; 38: 189-202.
10. Kawachi I, Willett WC, Colditz GA et al. A prospective study of coffee drinking and suicide in women. Arch Intern Med 1996; 156: 521-525.
11. Patten SB, Metz LM, Reimer MA. Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Mult Scler 2000; 6: 115-120.
12. Rihs M, Muuller C, Baumann P. Caffeine consumption in hospitalized psychiatric patients. Eur Arch Psychiatry Clin Neurosci 1996; 246: 83-92.
13. Leibenluft E, Fiero PL, Bartko JJ et al. Depressive symptoms and the self-reported use of alcohol, caffeine, and carbohydrates in normal volunteers and four groups of psychiatric outpatients. Am J Psychiatry 1993; 150: 294-301.
14. Silverman K, Evans SM, Strain EC et al. Withdrawal syndrome after the double-blind cessation of caffeine consumption. N Engl J Med 1992; 327: 1109-1114.
15. Hokanson JE, Sacco WP, Blumberg SR et al. Interpersonal behavior in depressive individuals in a mixed-motive game. J Abnorm Psychol 1980; 89: 320-332.
16. Tse WS, Bond AJ. Difference in serotonergic and noradrenergic regulation of human social behaviours. Psychopharmacology 2002; 159: 216-221.
17. Tse WS, Bond AJ. Serotonergic intervention affects both social dominance and affiliative behaviour. Psychopharmacology 2002; 161: 324-330.
18. Knutson B, Wolkowitz WM. Cole SW et al. Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry 1998; 155: 373 -379.
19. Durrant KL. Known and hidden sources of caffeine in drug, good, and natural products. J Am Pharm Assoc 2002; 42: 625-637.
20. Alsene K, Deckert J, Sand P et al. Association between A2A receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 2003; 28: 1694-1702.
21. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol 1988; 54: 1063-1070.
22. Rush CR, Sullivan JT, Griffiths RR. Intravenous caffeine in stimulant drug abusers: Subjective reports and physiological effects. J Pharmacol Exp Ther 1995; 273: 351-358.
23. Coyne JC. Depression and the response of others. J Abnorm Psychol 1976; 85: 186-193.
24. Tse WS, Bond AJ. Development and validation of the Two-Dimensional Social Interaction Scale (2DSIS). Psychiatry Res 2001; 103: 249-260.
25. Liguori A, Hughes JR, Grass JA. Absorption and subjective effects of caffeine from coffee, cola and capsules. Pharmacol Biochem Behav 1997; 58: 721-726.
26. Senn S. Cross-over Trials in Clinical Research. New York: Wiley, 1993.
27. Hills M, Armitage P. The two period cross-over clinical trial. Br J Clin Pharmacol 1979; 8: 7-20.
28. Holloway Jr WR, Thor DH. Acute and chronic caffeine exposure effects on play fighting in the juvenile rat. Neurobehav Toxicol Teratol 1984; 6: 85-91.
29. Minana MD, Grisolia S. Caffeine ingestion by rats increases noradrenaline turnover and result in biting. J Neurochem 1986; 47: 728-732.
30. Arciero PJ, Gardner AW, Benwitz NL et al. Relationship of blood pressure, heart rate and behavioral mood state to norepinephrine kinetics in younger and older following caffeine ingestion. Eur J Clin Nutr 1998; 52: 805-812.
31. Kamimori GH, Penetar DM, Headley DB et al. Effect of three caffeine doses on plasma catecholamines and alertness during prolonged wakefulness. Eur J Clin Pharmacol 2000; 56: 537-544.
32. Norager CB, Jensen MB, Weimann A et al. Metabolic effects of caffeine ingestion and physical work in 75-year old citizens. A randomized, double-blind, placebo-controlled, cross-over study. Clin Endocrinol 2006; 65: 223-228.
33. Papadelis C, Kourtidou-Papadeli C, Vlachogiannis E et al. Effects of mental workload and caffeine on catecholamines and blood pressure compared to performance variations. Brain Cogn 2003; 65: 143-154.
34. Smith A, Brice C, Nash J et al. Caffeine and central noradrenaline: Effects on mood, cognitive performance, eye movements and cardiovascular function. J Psychopharmacol 2003; 17: 283-292.